PE20070698A1 - Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol - Google Patents
Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxolInfo
- Publication number
- PE20070698A1 PE20070698A1 PE2006001419A PE2006001419A PE20070698A1 PE 20070698 A1 PE20070698 A1 PE 20070698A1 PE 2006001419 A PE2006001419 A PE 2006001419A PE 2006001419 A PE2006001419 A PE 2006001419A PE 20070698 A1 PE20070698 A1 PE 20070698A1
- Authority
- PE
- Peru
- Prior art keywords
- disgregation
- composition
- ambroxol hydrochloride
- amount
- tablet containing
- Prior art date
Links
- QNVKOSLOVOTXKF-UHFFFAOYSA-N 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;hydron;chloride Chemical compound Cl.NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1 QNVKOSLOVOTXKF-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000985 ambroxol hydrochloride Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 2
- 229960000913 crospovidone Drugs 0.000 abstract 2
- 239000007884 disintegrant Substances 0.000 abstract 2
- 239000008187 granular material Substances 0.000 abstract 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 abstract 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 abstract 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 239000004386 Erythritol Substances 0.000 abstract 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 235000019414 erythritol Nutrition 0.000 abstract 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 abstract 1
- 229940009714 erythritol Drugs 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001296 polysiloxane Polymers 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA SOLIDA TAL COMO UN COMPRIMIDO DE DISGREGACION RAPIDA INTRAORAL QUE COMPRENDE: A) UN GRANULO QUE TIENE UN ESPACIO VACIO DENTRO DEL MISMO QUE CONTIENE i) UN DESINTEGRANTE TAL COMO CROSPOVIDONA EN UNA CANTIDAD DE 4% A 20% EN PESO DE LA COMPOSICION; ii) HIDROCLORURO DE AMBROXOL; iii) ERITRITOL O MANITOL; B) UN DESINTEGRANTE UTILIZADO COMO RECUBRIMIENTO DEL GRANULO TAL COMO CROSPOVIDONA EN UNA CANTIDAD DE 4% A 20% EN PESO DE LA COMPOSICION; C) UN LUBRICANTE TAL COMO ACIDO SILICICO ANHIDRO LIGERO O UNA SAL DE ESTEARATO. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION. DICHA COMPOSICION SE DESINTEGRA RAPIDAMENTE CON UNA BUENA SENSACION EN LA CAVIDAD ORAL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005328722 | 2005-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20070698A1 true PE20070698A1 (es) | 2007-08-17 |
Family
ID=38023405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006001419A PE20070698A1 (es) | 2005-11-14 | 2006-11-13 | Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10300021B2 (es) |
| EP (2) | EP1951203A4 (es) |
| JP (2) | JP4934144B2 (es) |
| KR (1) | KR101298379B1 (es) |
| CN (2) | CN103637996A (es) |
| AR (1) | AR057581A1 (es) |
| AU (1) | AU2006312566B2 (es) |
| CA (1) | CA2629487C (es) |
| ES (1) | ES2702757T3 (es) |
| PE (1) | PE20070698A1 (es) |
| TW (1) | TWI478732B (es) |
| WO (2) | WO2007055427A1 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20070698A1 (es) | 2005-11-14 | 2007-08-17 | Teijin Pharma Ltd | Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol |
| WO2008120548A2 (ja) * | 2007-03-13 | 2008-10-09 | Dainippon Sumitomo Pharma Co., Ltd. | 口腔内崩壊錠 |
| GB2453770A (en) | 2007-10-19 | 2009-04-22 | Reckitt Benckiser Healthcare | Oral composition comprising a cooling agent |
| JP5835875B2 (ja) * | 2009-06-29 | 2015-12-24 | 富士化学工業株式会社 | 口腔内速崩壊錠の製造方法 |
| US8968779B2 (en) * | 2010-06-16 | 2015-03-03 | Teijin Pharma Limited | Controlled release coat-core tablet |
| NZ605562A (en) | 2010-07-09 | 2013-11-29 | Teijin Pharma Ltd | Deuterated benzylbenzene derivatives and methods of use |
| JP5697668B2 (ja) * | 2010-07-09 | 2015-04-08 | 帝人ファーマ株式会社 | 口腔内崩壊錠剤 |
| EP2665465A1 (en) * | 2011-01-17 | 2013-11-27 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
| WO2013001441A1 (en) * | 2011-06-29 | 2013-01-03 | Ranbaxy Laboratories Limited | Dry formulations of febuxostat |
| JP6823913B2 (ja) * | 2014-06-18 | 2021-02-03 | 大正製薬株式会社 | 固形製剤 |
| JP6073843B2 (ja) * | 2014-09-10 | 2017-02-01 | 佐藤製薬株式会社 | 硬度及び崩壊性に優れた口腔内崩壊錠の製造方法及び該製造方法により製造される口腔内崩壊錠 |
| JP6718866B2 (ja) | 2014-10-16 | 2020-07-08 | カーギル インコーポレイテッド | 直接圧縮性のエリスリトールの調製方法及びその使用 |
| ES2982524T3 (es) * | 2016-06-16 | 2024-10-16 | Towa Pharmaceutical Co Ltd | Comprimido de disgregación por vía oral |
| TWI767923B (zh) * | 2016-07-27 | 2022-06-21 | 日商澤井製藥股份有限公司 | 口腔內崩解錠添加用組成物及其製造方法以及口腔內崩解錠 |
| JP6201017B2 (ja) * | 2016-08-04 | 2017-09-20 | 佐藤製薬株式会社 | 硬度及び崩壊性に優れた口腔内崩壊錠の製造方法及び該製造方法により製造される口腔内崩壊錠 |
| TWI650142B (zh) * | 2016-09-06 | 2019-02-11 | 日商澤井製藥股份有限公司 | 口腔内崩解錠添加用組成物 |
| US20220409591A1 (en) * | 2019-11-18 | 2022-12-29 | Zycie Technolegal Llp | Pharmaceutical Formulations for Managing Uric Acid Content in Human Body |
| JP7486258B2 (ja) * | 2019-12-26 | 2024-05-17 | 物産フードサイエンス株式会社 | 口腔内崩壊錠用顆粒、その製造方法および口腔内崩壊錠 |
| JP7195660B1 (ja) | 2021-09-09 | 2022-12-26 | 壽製薬株式会社 | 口腔内崩壊錠 |
| KR20230087405A (ko) | 2021-12-09 | 2023-06-16 | 블룸 에너지 코퍼레이션 | 연료 활용도가 100 퍼센트에 가까운 연료 전지 시스템 및 이의 동작 방법 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US134199A (en) * | 1872-12-24 | Improvement in car-couplings | ||
| US49315A (en) * | 1865-08-08 | Improvement in photographic cameras | ||
| US215500A (en) * | 1879-05-20 | Improvement in distance-instruments | ||
| US112196A (en) * | 1871-02-28 | Improvement in horse-collars | ||
| US98227A (en) * | 1869-12-28 | Improved railway-car | ||
| US4684516A (en) * | 1983-08-01 | 1987-08-04 | Alra Laboratories, Inc. | Sustained release tablets and method of making same |
| JP3069458B2 (ja) | 1992-01-29 | 2000-07-24 | 武田薬品工業株式会社 | 口腔内崩壊型錠剤およびその製造法 |
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| DK0922464T3 (da) * | 1996-07-12 | 2005-06-06 | Daiichi Seiyaku Co | Hurtigt desintegrerbare, kompressionsstöbte materialer og fremgangsmåder til fremstilling af samme |
| AR016827A1 (es) | 1997-08-22 | 2001-08-01 | Smithkline Beecham Corp | PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA |
| JP3786578B2 (ja) | 1997-11-18 | 2006-06-14 | 帝人ファーマ株式会社 | 環状アミン誘導体、およびその薬剤としての使用法 |
| UA52797C2 (uk) | 1997-11-20 | 2003-01-15 | Тейдзін Лімітед | Похідне біфеніламідину, проліки, інгібітор коагуляції крові, агент для профілактики тромбозу або емболії та агент для терапії тромбозу або емболії |
| CA2338446C (en) * | 1998-07-24 | 2010-02-09 | Franz Sen. Haas | Use of erythritol and/or xylitol in baking mixtures or dough for non-perishable baked goods of flour and/or starches as partial or complete replacements for sugar |
| ATE291418T1 (de) | 1998-07-28 | 2005-04-15 | Takeda Pharmaceutical | Leicht zerfallende feste zubereitung |
| FR2795962B1 (fr) | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
| DE60130865T2 (de) | 2000-01-17 | 2008-07-17 | Teijin Pharma Ltd. | Benzimidazol-derivate als menschliche chymase - inhibitoren |
| JP3415835B2 (ja) | 2000-06-30 | 2003-06-09 | 山之内製薬株式会社 | 口腔内速崩壊錠およびその製造法 |
| UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| JP4358117B2 (ja) * | 2001-03-06 | 2009-11-04 | 協和発酵キリン株式会社 | 口腔内速崩壊錠 |
| CA2439873A1 (en) * | 2001-03-06 | 2002-09-12 | Kyowa Hakko Kogyo Co., Ltd. | Intraorally rapidly desintegrable tablet |
| FR2823668B1 (fr) * | 2001-04-20 | 2004-02-27 | Ethypharm Lab Prod Ethiques | Comprimes effervescents orodispersibles |
| KR101099176B1 (ko) * | 2003-01-21 | 2011-12-27 | 니뽄 신야쿠 가부시키가이샤 | 구강내 속붕성 정제 |
| SI21403A (sl) | 2003-02-27 | 2004-08-31 | LEK farmacevtska dru�ba d.d. | Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo |
| US20050042277A1 (en) * | 2003-07-17 | 2005-02-24 | Irukulla Srinivas | Pharmaceutical compositions having a swellable coating |
| US20050112196A1 (en) | 2003-10-07 | 2005-05-26 | Jianbo Xie | Rapidly disintegrating formulation |
| JP4592272B2 (ja) | 2003-10-08 | 2010-12-01 | シャープ株式会社 | 給紙カセットおよび給紙装置 |
| US9884014B2 (en) * | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| JP5123517B2 (ja) | 2005-11-14 | 2013-01-23 | 帝人ファーマ株式会社 | アンブロキソール口腔内速崩性錠剤 |
| PE20070698A1 (es) | 2005-11-14 | 2007-08-17 | Teijin Pharma Ltd | Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol |
| WO2008122993A1 (en) | 2007-04-09 | 2008-10-16 | Panacea Biotec Limited | Controlled release formulation of coated microparticles |
-
2006
- 2006-11-13 PE PE2006001419A patent/PE20070698A1/es not_active Application Discontinuation
- 2006-11-14 WO PCT/JP2006/323061 patent/WO2007055427A1/en not_active Ceased
- 2006-11-14 AR ARP060104991A patent/AR057581A1/es unknown
- 2006-11-14 EP EP06823463A patent/EP1951203A4/en not_active Withdrawn
- 2006-11-14 CA CA2629487A patent/CA2629487C/en not_active Expired - Fee Related
- 2006-11-14 US US12/092,852 patent/US10300021B2/en not_active Expired - Fee Related
- 2006-11-14 EP EP06823462.4A patent/EP1957051B1/en not_active Not-in-force
- 2006-11-14 AU AU2006312566A patent/AU2006312566B2/en not_active Ceased
- 2006-11-14 WO PCT/JP2006/323062 patent/WO2007055428A1/en not_active Ceased
- 2006-11-14 JP JP2008539669A patent/JP4934144B2/ja not_active Expired - Fee Related
- 2006-11-14 ES ES06823462T patent/ES2702757T3/es active Active
- 2006-11-14 CN CN201310682491.8A patent/CN103637996A/zh active Pending
- 2006-11-14 KR KR1020087014401A patent/KR101298379B1/ko not_active Expired - Fee Related
- 2006-11-14 TW TW095142089A patent/TWI478732B/zh not_active IP Right Cessation
- 2006-11-14 CN CN200680042409.3A patent/CN101309672B/zh not_active Expired - Fee Related
-
2009
- 2009-09-18 US US12/562,674 patent/US9511029B2/en not_active Expired - Fee Related
-
2011
- 2011-08-10 JP JP2011175017A patent/JP2011225624A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1951203A4 (en) | 2011-07-06 |
| CA2629487C (en) | 2014-11-18 |
| AU2006312566B2 (en) | 2012-04-12 |
| EP1957051B1 (en) | 2018-11-14 |
| CA2629487A1 (en) | 2007-05-18 |
| JP2009515871A (ja) | 2009-04-16 |
| US20100009004A1 (en) | 2010-01-14 |
| AR057581A1 (es) | 2007-12-05 |
| JP2011225624A (ja) | 2011-11-10 |
| WO2007055428A1 (en) | 2007-05-18 |
| TW200738282A (en) | 2007-10-16 |
| EP1957051A1 (en) | 2008-08-20 |
| US20090117182A1 (en) | 2009-05-07 |
| KR20080073335A (ko) | 2008-08-08 |
| EP1957051A4 (en) | 2011-07-06 |
| WO2007055427A1 (en) | 2007-05-18 |
| AU2006312566A1 (en) | 2007-05-18 |
| CN101309672A (zh) | 2008-11-19 |
| US10300021B2 (en) | 2019-05-28 |
| EP1951203A1 (en) | 2008-08-06 |
| JP4934144B2 (ja) | 2012-05-16 |
| CN101309672B (zh) | 2015-07-29 |
| KR101298379B1 (ko) | 2013-08-20 |
| US9511029B2 (en) | 2016-12-06 |
| ES2702757T3 (es) | 2019-03-05 |
| CN103637996A (zh) | 2014-03-19 |
| TWI478732B (zh) | 2015-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20070698A1 (es) | Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol | |
| AR054139A1 (es) | Formulacion modificada y de liberacion inmediata de esferas de memantina | |
| CY1121107T1 (el) | Φαρμακοτεχνικες μορφες δισκιων αμεσης απελευθερωσης | |
| ECSP088973A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| PE20131352A1 (es) | Composicion farmaceutica que contiene un agonista del receptor s1p y un alcohol de azucar | |
| CO6400186A2 (es) | Tabletas de acetato de ulipristal | |
| MX374797B (es) | Formulaciones farmaceuticas que contienen hidrato de propilenglicol de dapagliflozina. | |
| ECSP088974A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| CR20110435A (es) | Formulaciones de 4-amino-2-(2,6-dioxopiperidina-3-il) isoindolina-1,3-diona | |
| UY27350A1 (es) | Azaindoles | |
| PE20140960A1 (es) | Formulaciones que comprenden un inhibidor de dpp4 | |
| AR066130A1 (es) | Formas cristalinas de saxagliptina y procesos para preparar las mismas | |
| CL2008002768A1 (es) | Compuestos derivados de carboxiciclopropil-(bis-fenil-oxamidas); composicion farmaceutica que los contiene; procedimiento para la elaboracion de las composiciones y el uso de los compuestos en el tratamiento de diabetes y trastornos del sncentre otras enfermedades. | |
| CR10027A (es) | Nuevos derivados de pirrol fusionado | |
| BRPI0709847B8 (pt) | composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcio | |
| ATE454132T1 (de) | Rasch in der mundhöhle schmelzende tablette | |
| CO6382089A2 (es) | Compuestos,composiciones y metodos para el tratamiento de enfermadades causadas por un b-amiloide y sinucleinopatias | |
| CO6270217A2 (es) | Formulaciones galenicas de alisquireno y valsartan | |
| PE20130657A1 (es) | Composiciones farmaceuticas que comprenden hidromorfona y naloxona | |
| MX2016014771A (es) | Forma de dosificacion oralmente desintegrante para administracion de avanafil, y metodos de fabricacion y uso asociados. | |
| CR9722A (es) | Derivados de benzilpiperazina y su uso medico | |
| CL2008001820A1 (es) | Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer. | |
| TN2015000135A1 (en) | Modified release formulations for oprozomib | |
| EA201170695A1 (ru) | Улучшенная стабильность таблеток карбоната кальция при растворении | |
| BR122021012549B8 (pt) | Composição de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FX | Voluntary withdrawal |